参考文献/References:
[1] GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease study 2016[J]. Lancet, 2017, 390(10100): 1151-1210.
[2] HAN Xiudi, LIU Xuedong, CHEN Liang, et al. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients[J]. BMC Infectious Diseases, 2020, 20(1): 668.
[3] WU Xiaodong, LI Yuanyuan, ZHANG Ming, et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing: a prospective multicenter study[J]. Infectious Diseases and Therapy, 2020, 9(4): 1003-1015.
[4] WANG Chuwen, YAN Danying, HUANG Jiajia, et al. The clinical application of metagenomic next-generation sequencing in infectious diseases at a tertiary hospital in China[J]. Frontiers in Cellular and Infection Microbiology, 2022, 12: 957073.
[5] DENG Wenhua, XU Huan, WU Yabin, et al. Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia[J].Frontiers in Cellular and Infection Microbiology, 2022, 12: 950531.
[6] DAI Yi, SHENG Kai, HU Lan. Diagnostic efficacy of targeted high-throughput sequencing for lower respiratory infection in preterm infants[J]. American Journal of Translational Research, 2022, 14(11): 8204-8214.
[7] DAVIDSON K R, HA D M, SCHWARZ M I, et al. Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases[J]. Journal of Thoracic Disease, 2020, 12(9): 4991-5019.
[8] HUANG Jie, JIANG Erlie, YANG Donglin, et al. Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions[J]. Infection and Drug Resistance, 2020, 13: 567-576.
[9] SHI Cuilin, HAN Peng, TANG Peijun, et al. Clinical metagenomic sequencing for diagnosis of pulmonary tuberculosis[J]. Journal of Infection, 2020, 81(4): 567-574.
[10] MIAO Qing, MA Yuyan, WANG Qingqing, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice[J]. Clinical Infectious Diseases, 2018, 67(suppl_ 2): S231-S240.
[11] NIELSEN M C, CLARNER P, PAROHA R, et al. Comparison of analytical sensitivity (limit of detection) of xpert MTB/RIF and xpert MTB/RIF ultra for non-sputum specimens[J]. Pathogens, 2023, 12(2): 157.
[12] MITCHELL S L, SIMNER P J. Next-generation sequencing in clinical microbiology: are we there yet?[J]. Clinics in Laboratory Medicine, 2019, 39(3): 405-418.
[13] LIN Pengcheng, CHEN Yi, SU Shanshan, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients[J]. BMC Infectious Diseases, 2022, 22(1): 416.
[14] PENG Jinmin, DU Bin, QIN Hanyu, et al. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients[J].Journal of Infection, 2021, 82(4): 22-27.
[15] ZHENG Yan, QIU Xiaojian, WANG Ting, et al. The diagnostic value of metagenomic next-generation sequencing in lower respiratory tract infection[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11: 694756.
[16] GRENINGER A L. The challenge of diagnostic metagenomics[J]. Expert Review of Molecular Diagnostics, 2018, 18(7): 605-615.
[17] 中华医学会检验医学分会. 高通量宏基因组测序技术检测病原微生物的临床应用规范化专家共识[J].中华检验医学杂志, 2020, 43( 12): 1181-1195. Chinese Society of Laboratory Medicine. Expert consensus on clinical standardized application of metagenomics next-generation sequencing for detection of pathogenic microorganisms [J]. Chinese Journal of Laboratory Medicine, 2020, 43(12): 1181-1195.
[18] LI Shiying, TONG Jin, LIU Yi, et al. Targeted next generation sequencing is comparable with metagenomic next generation sequencing in adults with pneumonia for pathogenic microorganism detection[J]. Journal of Infection, 2022, 85(5): e127-e129.
[19] GASTON D C, MILLER H B, FISSEL J A, et al. Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens[J]. Journal of Clinical Microbiology, 2022, 60(7): e0052622.
[20] GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease study 2019[J]. Lancet, 2022, 400(10369): 2221-2248.
[21] 邸师红, 马倩, 代超, 等.重症监护病房脓毒血症患者病原学分布及死亡高危因素分析[J]. 现代检验医学杂志, 2020, 35( 3): 141-145. DI Shihong, MA Qian, DAI Chao, et al. Etiology distribution and risk factors of death in patients with severe sepsis in intensive care unit[J]. Journal of Modern Laboratory Medicine, 2020, 35(3): 141-145.
相似文献/References:
[1]周道银,吴 茅,许绍强,等.支气管肺泡灌洗液细胞形态学检验中国专家共识[J].现代检验医学杂志,2020,35(06):4.[doi:doi:10.3969/j.issn.1671-7414.2020.06.002]
ZHOU Dao-yin,WU Mao,XU Shao-qiang,et al.Consensus of Chinese Experts on Morphological Examination of Bronchoalveolar Lavage Fluid Cells(2020)[J].Journal of Modern Laboratory Medicine,2020,35(05):4.[doi:doi:10.3969/j.issn.1671-7414.2020.06.002]
[2]君安医学细胞平台专家委员会.支气管肺泡灌洗液细胞形态学检验中国专家共识(2023)[J].现代检验医学杂志,2023,38(03):11.[doi:10.3969/j.issn.1671-7414.2023.03.003]
Expert Committee of J.EDU Medical Cell Platform Soliciting Contributions.Consensus of Chinese Experts on Morphological Examination of Bronchoalveolar Lavage Fluid Cells ( 2023)[J].Journal of Modern Laboratory Medicine,2023,38(05):11.[doi:10.3969/j.issn.1671-7414.2023.03.003]
[3]罗世龙a,李志强b,李 翔a.肺癌患者支气管肺泡灌洗液中DAPL1 和MLH1 基因甲基化水平检测及其临床意义研究[J].现代检验医学杂志,2024,39(05):125.[doi:10.3969/j.issn.1671-7414.2024.05.023]
LUO Shilonga,LI Zhiqiangb,LI Xianga.Detection and Clinical Significance of DAPL1 and MLH1 Gene Methylation in Bronchoalveolar Lavage Fluid of Lung Cancer Patients[J].Journal of Modern Laboratory Medicine,2024,39(05):125.[doi:10.3969/j.issn.1671-7414.2024.05.023]